Seppo Kaakkola

Professor Kaakkola earned his MD degree in 1978 and PhD in 1981 from the Department of Pharmacology, University of Helsinki. Following training in pharmacology and clinical pharmacology he moved to the Department of Neurology in Helsinki University Central Hospital where he is still working. Docent (Senior Lecturer) in neurology since 1990, and in 2010 the President of Finland awarded him the title Professor. Professor Kaakkola has been the Chief Physician of Out-patient Department and at present is responsible for the movement disorders unit at Out-patient Department of Helsinki University Central Hospital. His main research interests include dopamine, Parkinson’s disease and other movement disorders and drug development. He was involved in development of entacapone (a COMT inhibitor, Orion Pharma) for Parkinson’s disease both at the preclinical and clinical phases. Professor Kaakkola has a long history of active collaboration with patient organizations, including the Finnish Parkinson Foundation and the Finnish Multiple Sclerosis Society.